chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After the injection I felt fine. After falling asleep that evening, I awoke around 12:30am with body aches and slight amount of nausea.  It lasted for a few hours through the night in which I did not sleep.
Approximately 20 hours after receiving the vaccine, my hands and feet became very cold, and my whole body began to shake - have chills, and my teeth began chattering.  Approximately 3 hours later, I began to feel warm; my eyelids were very warm whenever I blinked.  Slowly but surely I began to feel better.
She received ZOSTAVAX 8/5/08 and developed shingles lesions on her right buttock with pain in right thigh
MMR/HIB given -  went to sleep, awoke screaming & crying, welts on back, face & stomach as reported by mom. Head banging irritable w/ violent outbursts. MD phoned recommended cool bath & tylenol & Benadryl.
Initial report was received from the literature on 20 December 2013. The following is verbatim from the article abstract: IMPORTANCE: Undervaccination is an increasing trend that potentially places children and their communities at an increased risk for serious infectious diseases. OBJECTIVE: To examine the association between undervaccination and pertussis in children 3 to 36 months of age. DESIGN: Matched case-control study with conditional logistic regression analysis. SETTING Eight managed care organizations of the Vaccine Safety Datalink between 2004 and 2010. PARTICIPANTS: Each laboratory-confirmed case of pertussis (72 patients) was matched to 4 randomly selected controls (for a total of 288 controls). The case patients were matched to controls by managed care organization site, sex, and age at the index date. The index date was defined as the date of pertussis diagnosis for the case patients. EXPOSURE: Undervaccination for the DTaP. Undervaccination was defined as the number of doses of DTaP that was either missing or delayed by the index date. Case patients and controls could be under vaccinated by 0, 1, 2, 3, or 4 doses of DTaP. Children undervaccinated by 0 doses were considered age-appropriately vaccinated by the index date. MAIN OUTCOME AND MEASURE: Pertussis. RESULTS Of the 72 case patients with pertussis, 12 (16.67%) were hospitalized, and 34 (47.22%) were under vaccinated for DTaP by the date of pertussis diagnosis. Of the 288 matched controls, 64 (22.22%) were under vaccinated for DTaP. Under vaccination was strongly associated with pertussis. Children under vaccinated for 3 or 4 doses of DTaP were 18.56 (95%CI, 4.92-69.95) and 28.38 (95%CI, 3.19-252.63) times more likely, respectively, to have received a diagnosis of pertussis than children who were age-appropriately vaccinated. CONCLUSIONS AND RELEVANCE: Under vaccination with DTaP increases the risk of pertussis among children 3 to 36 months of age.
Soreness at the injection site; Itching under the skin where the injection was given; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching under the skin where the injection was given) and VACCINATION SITE PAIN (Soreness at the injection site) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the injection site). In May 2021, the patient experienced VACCINATION SITE PRURITUS (Itching under the skin where the injection was given). In May 2021, VACCINATION SITE PAIN (Soreness at the injection site) had resolved. At the time of the report, VACCINATION SITE PRURITUS (Itching under the skin where the injection was given) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medication were reported.  No treatment medication were reported.  Patient had soreness at the injection site, but this disappeared on an unspecified date. He now reports that he has itching under the skin where the injection was given, and this has persisted for over a week now. The patient also reported that the events had no negative impact on him.    Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Action taken, vaccination site pruritus outcome and listedness sections were updated.
pt recv vax 23OCT98 & 25OCT98 presented to ER w/sx similar to anaphylactic rxn including resp distress & hypotension;treated & sent home;
Patient called explaining she experienced nausea, headache, and chills the day after receiving her second SHINGRIX dose. She is now 5 days post immunization and explains from raised, itchy red bumps right below the injection site. Patient went to urgent care, where she was advised to apply topical antihistamine cream and take oral BENADRYL as needed for itching. I further advised her to apply cold compress and take ibuprofen as needed for comfort. Patient is aware vaccine is not live, and patient is not worried reaction is due to herpes zoster virus itself.
Local reaction - skin surrounding vaccine site erythematous, warm, and indurated for 3-4 days.
PATIENT STARTED COUGHING, AFTER RECEIVING VACCINE. PATIENT WAS MONITORED, DRANK WATER, AND GIVEN 25MG BENADRY PO.
Burning headache on top of my head leaving and coming back; Nausea; Diarrhea; All noises irritating were irritating to me; High blood pressure; Very tired all day; Soreness and redness at injection site; Soreness and redness at injection site; Felt funny, shittery and something like an out of the body experience; Pain at injection site; week muscles on the back of the leg and arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Pain at injection site), MUSCULAR WEAKNESS (week muscles on the back of the leg and arm), HEADACHE (Burning headache on top of my head leaving and coming back), FATIGUE (Very tired all day) and INJECTION SITE DISCOMFORT (Soreness and redness at injection site) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included CT scan. Concurrent medical conditions included Psoriasis. Concomitant products included ESTRADIOL, ROSUVASTATIN, TELMISARTAN, CAPTOPRIL (METOPRIL) and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication, CLONIDINE.  On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced INJECTION SITE PAIN (Pain at injection site), MUSCULAR WEAKNESS (week muscles on the back of the leg and arm), FATIGUE (Very tired all day), INJECTION SITE DISCOMFORT (Soreness and redness at injection site), INJECTION SITE ERYTHEMA (Soreness and redness at injection site) and FEELING ABNORMAL (Felt funny, shittery and something like an out of the body experience). On 09-Jan-2021, the patient experienced NAUSEA (Nausea), DIARRHOEA (Diarrhea), IRRITABILITY (All noises irritating were irritating to me) and HYPERTENSION (High blood pressure). On an unknown date, the patient experienced HEADACHE (Burning headache on top of my head leaving and coming back). On 08-Jan-2021, INJECTION SITE PAIN (Pain at injection site) and MUSCULAR WEAKNESS (week muscles on the back of the leg and arm) had resolved. On 09-Jan-2021, NAUSEA (Nausea), DIARRHOEA (Diarrhea) and IRRITABILITY (All noises irritating were irritating to me) had resolved. On 10-Jan-2021, HEADACHE (Burning headache on top of my head leaving and coming back), FATIGUE (Very tired all day), INJECTION SITE DISCOMFORT (Soreness and redness at injection site), INJECTION SITE ERYTHEMA (Soreness and redness at injection site) and FEELING ABNORMAL (Felt funny, shittery and something like an out of the body experience) had resolved. On 12-Jan-2021, HYPERTENSION (High blood pressure) had resolved.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information provided includes Xanax, Tylenol and Zofran.
Hard of hearing; This is a spontaneous report from a Pfizer-sponsored program,SUPPORT. A non-contactable consumer (patient) reported that a male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number was not reported), via an unspecified route of administration, on an unspecified date, as dose 1, single, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the first shot and needs to get scheduled for the second shot. On an unspecified date, the patient was hard of hearing. The outcome of the event was unknown. No follow-up attempts are possible; information about lot or batch number cannot be obtained. No further information is expected.
sick; This is a spontaneous report from a Pfizer-sponsored program, Support. A contactable consumer (patient) reported that a female patient of unspecified age received unknown dose number of BNT162B2 (Covid-19 Vaccine), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient has been sick for the last few days on unspecified date. Outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
stomach cramps beginning 21 hours after vaccine, intermittent, lasted for approximately 3.5 days headache and jaw pain beginning 2 days after vaccine, still continuing dizziness beginning 2 days after vaccine, still continuing
As per parent, student fell asleep as soon as he got home. Did not eat until after 4:30pm. Student felt fatigued and had a 30 second convulsion.
SM tested negative BHCG on 30Mar2009.  SM received Anthrax and Smallpox on 2Apr2009.  SM tested positive BHCG on 4May2009.  Last Menstrual Period was 16Mar2009
PATIENT WAS GIVEN A BOOSTER DOSE OF 0.5MLS INSTEAD OF 0.25MLS FOLLOWING THE JANSSEN VACCINE. PATIENT EXPERIENCED SOME FATIGUE. WHEN I SPOKE WITH PATIENT SHE SAID SHE WAS 20 WEEKS PREGNANT. HER DOCTOR IS AWARE OF THE SITUATION AND THERE ARE NO PROBLEMS AT THIS TIME. WILL CONTINUE TO FOLLOW UP AND REPORT ANY ISSUES.
This spontaneous report as received from a Registered Nurse refers to multiple patients of unknown ages and genders. Medical history and current conditions were not reported. On an unknown dates over an unspecified 7 month period, the patients were vaccinated with improperly stored doses of ROTATEQ lot number L033693, expiration date 31-MAY-2017, and lot number L033694, expiration date 16-JUN-2017. Dose and route of administration were not provided. No other suspect or concomitant medications were reported. As reported, temperature uncertain, surmising worst case 51 F for 7 months; digital data logger was involved. Previous: uncertain. No adverse effects were reported. This is one of four reports received from the same reporter. Additional information has been requested.
This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness, fever and pain in arm. On an unknown date, the outcome of the sickness, fever and pain in arm were recovered/resolved. It was unknown if the reporter considered the sickness, fever and pain in arm to be related to Shingles vaccine. Additional details were reported as follows: The case was reported by the patient's parent. The age at vaccination was not reported. The reporter said if you had chickenpox you still get shingles also said if you get the shingles vaccination you could still get shingles, usually a lighter case. The patient just got the shingles vaccination which made him sick, had fever and his arm was sore for over a week. Not sure the patient would go back for second shot. No contact details were available. The case had been linked with US2021AMR248169 reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR248169:same reporter/ invalid report.
Heart rate increase, flushed for about 20 minutes. She has an internal monitor/defibrillator.  States "it feels like when they do a dvice check."
Chest started to retract severely. Temperature spiked to 104. Gasping for air. Treatment was PCU for the next three days then sent home only to return to the hospital over five times in the next two weeks.  He stopped breathing, SIDS, when in the hospital on monitors.
itchy; red, bumpy and itchy; rashes on her shoulder her abdomen and one leg; body aches; she was tired; she had a migraine; flu like symptoms; she had a sore arm; A spontaneous report was received from a consumer concerning a 65-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events sore arm, migraine, flu symptoms, body aches, tired, rashes, bumpy, itchy.  The patient's medical history was not provided. Concomitant medications reported were Vitamin D3, probiotic for drug use for unknown indication.  On 1 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 026L20A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.  On 1 Feb 2021, the patient experienced the event(s) sore arm,On 2 Feb 2021, the patient experienced the event(s) migraine, flu symptoms, body aches, tired. On 9 Feb 2021, the patient experienced the event(s) rashes, bumpy, itchy.  Treatment details included Tylenol.  Action taken with mRNA-1273 in response to the events was not reported.  On 3 Feb 2021 the outcome of event(s), migraine, body aches was resolved. The outcome of event(s), sore arm, flu symptoms, tired, rashes, bumpy, itchy was unknown.
3/1/2023 Started to feel like I was coming down with something. This became full sinus pressure in the face with headache, and runny nose. Tested with an At Home COVID-19 test, positive. Tele-visit with doctor who proscribed Paxlovid and to treat symptomatically. Treated with Nyquil and Dayquil. Symptoms stays the same until 3/4/23 and then symptoms gradually got better. Symptoms got much worse on 3/13/23 with a visit to Urgent care on 3/15 due to tightness of chest. Doctors there performed an EKG and a chest X-ray. Doctors noted some T-Wave abnormalities and referred to the Cardiologist. Cardiologist follow up has not happened yet at time of reporting. Participant reports symptoms getting better very gradually until 4/1/23.
A 54 year old male reported that he received an injection of Flu Shield '00-'01 on 11/30/00. On 12/1/00, he developed redness and itching over his entire body. He also developed "dime-sized" hives at he injection site. He was treated with methylprednisolone. The hives resolved. As of 12/4/00, the redness and itching persisted. Follow up information received from the physician on 01/05/2001 indicated that the patient recovered.
Patient presented for second dose - reported feeling dizzy while in the observation area.   Upon getting home she felt like her throat was closing and her chest was tight, heart pounding, cheeks were flushed and painful.  These symptoms lasted 10 minutes.  She applied cold compresses to her cheeks.  After 10 minutes she began to feel better.  She did not seek treatment or call her doctor.
25MAY91 became fussy, crying hysterically, did sleep off & on; 26MAY rash appeared; 27MAY rash worse covering entire body, feet swollen; 28MAY91 eyes swollen 29MAY seen by MD;Glands swollen, throat culture;T 101-102
Hard and red round spot near injection site.  Hot to the touch.  Not sure if related but also throwing up this morning.
I had COVID in October 2020. My repeat antibody testing for spike and nucleocapsid remained high q2months with testing. I had 1st Pfizer 7/15/21. Second dose 8/3/21.  First dose I had fatigue, arm soreness, mild headache, mild total body myalgias.  Second dose, around 12-13 hours after the injection I had severe myalgias, rigors, headache, insomnia. It lasted until around 8am then started to wane until 2pm the next day. I took 1000mg tylenol around midnight and then again at 8am. It was like mini early COVID again for me. I expected this type of reaction but just reporting since it was severe. I also developed a rash on my neck the AM after the injection. It resolved over 1 week and I used hydrocortisone cream sparingly on it after day 3 until day 7.
Initial and follow-up information has been received from a registered nurse and pediatrician concerning a 7 month old male who on 09-DEC-2008 was vaccinated orally with a dose of ROTATEQ vaccine (lot # 661579/0899X) stored in the freezer or refrigerator which temperature was not logged from 10-OCT-2008 to 18-DEC-2008. The nurse stated that people in the office switched positions and failed to document the temperatures. The freezer was working fine but there were no readings documented. No adverse effect reported. The pediatrician noted that the patient was to be followed. This is one of several reports from the same source. Additional information is not expected.
Initial report received from a health care professional on Nov 21 2005. A 44 year old female received an injection of Fluzone SV 2005-2006 USP on Nov 4 2005. Eight days later the patient gradually developed weakness of her lower extremities. The weakness progressed to where the patient was unable to walk, She was hospitalized and diagnosed with Guillain Barre syndrome. No information was provided regarding the patients treatment. At the time of this report, the patient was improving, but was in rehabilitation. She has not recovered from the events.
Feels off balance; Riningin in ears/Ringing in ears sounds muffled/Ringing in ears is painful; Not feeling well; Loss of appetite; Slept majority of the day; Diarrhea; Felt tired; Fever; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Slept majority of the day), DIARRHOEA (Diarrhea), MALAISE (Not feeling well), DECREASED APPETITE (Loss of appetite) and TINNITUS (Riningin in ears/Ringing in ears sounds muffled/Ringing in ears is painful) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included DULAGLUTIDE (TRULICITY), COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), VALSARTAN (VALSARTAN AL), CARVEDILOL (CARVEDILOL BP), TORSEMIDE and POTASSIUM for an unknown indication.    On 19-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jun-2021, the patient experienced SOMNOLENCE (Slept majority of the day), DIARRHOEA (Diarrhea), DECREASED APPETITE (Loss of appetite), FATIGUE (Felt tired) and PYREXIA (Fever). On 20-Jun-2021, the patient experienced MALAISE (Not feeling well) and TINNITUS (Riningin in ears/Ringing in ears sounds muffled/Ringing in ears is painful). On an unknown date, the patient experienced BALANCE DISORDER (Feels off balance). On 22-Jun-2021, PYREXIA (Fever) had resolved. At the time of the report, SOMNOLENCE (Slept majority of the day), DIARRHOEA (Diarrhea), MALAISE (Not feeling well), DECREASED APPETITE (Loss of appetite), TINNITUS (Riningin in ears/Ringing in ears sounds muffled/Ringing in ears is painful), BALANCE DISORDER (Feels off balance) and FATIGUE (Felt tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Warm Transfer From Moderna Customer Care, Case # 00176354, on 22Jun2021.
On 1/14/2021 @ 0659, patient was noted to be weaker, arms were flaccid R>L. Unable to answer questions speech gargled. Unable to grasp hands. Pupils reactive, but sluggish. Probable CVA. Dr. and family were notified. Family wished to keep patient at hospital and provide comfort care rather than send to the hospital. MD was in agreement. APNP, assessed patient. Her tongue was red and swollen. Bite marks noted on right side of tongue likely d/t event. ST evaluation done to evaluate patient's ability to chew and swallow safely due to swelling of tongue. Hospice services were initiated. (Unsure if event was caused by vaccine administration)
Pt. received vaccines 1/27/12, developed rash 2 days after receiving vaccines. Rash was erythema multiforme, associated with edemas of hands & feet.
"Severe fatigue, chills, hot feeling, headache, body aches and neck pain, along with redness and swelling approximately 4 inches in diameter, he was afebrile. Symptoms lasted for 2 days.
Information has been received from a registered nurse concerning a 7 year old female consumer with no known allergies or pertinent medical history who on 18-DEC-2007 was vaccinated SQ with a second dose of 0.5ml of varicella virus vaccine live (Oka/Merck) (lot # 659610/1654U). The patient was vaccinated with the first dose of varicella virus vaccine live (Oka/Merck) (lot number unspecified) on 05-DEC-2001. There was no illness at the time of this vaccination. Concomitant vaccinations on 18-DEC-2007 included a first dose of HAVRIX (lot # AHA6BZ11AA) in the left arm. Subsequently, on 27-FEB-2008 the patient developed varicella. She had 4 to 5 blisters and pruritus. The patient was seen by the physician, who diagnosed her with varicella. There were no lab studies performed. The patient recovered 10 days later in 08-Mar-2008. There was no product quality complaint involved. Additional information has been requested. The patient's brother also had an adverse event after vaccination with varicella virus vaccine live (Merck) (waes # 0802USA060811). Additional information is not expected.
2-3hr p/vax pt was @ daycare & was noted to look flushed;temp was taken & said to be 105;was immed brought to office where temp was 100.7 & rash was gone;
Client became diaphoretic and lethargic. We called 911 and client refused to go to hospital and picked up by a friend
Pain at injection site. Muscle cramps, chills, shivering, teeth chattering, muscle soreness followed by joint soreness, major headache, temperature of 101.8, waves of nausea
Muscle pain; Temperature of 99.3F/Fever; Arm pain; Headache; Feeling really tired / fatigue; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 63-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 19th October 2021, the patient received the 1st dose of Shingrix. On 19th October 2021, less than a day after receiving Shingrix, the patient experienced pain in arm, headache and tiredness. On 20th October 2021, the patient experienced muscle pain and fever. On an unknown date, the outcome of the pain in arm, headache, tiredness, muscle pain and fever were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm, headache, tiredness, muscle pain and fever to be related to Shingrix.  Additional details were provided as follows: The reporter was the patient. The patient received the Shingrix vaccine at the doctor's office and reported that he had arm pain, headache and was feeling really tired on the same day as he received the vaccine. At the reporting date, he had muscle pain, fatigue and a temperature of 99.3F.  The reporter wanted to knowhow long after receiving Shingrix should he might experience side effects.   The reporter did not consent to follow-up and was not willing to provide contact details of the physician